KV1.3 (KCNA3) and calcium-activated KCa3.1 channels are primarily responsible for K+ efflux and are important therapeutic targets in various autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis, and type-1 diabetes (Chandy and Norton, 2017). This evidence concerns the gene KCNA3 and rheumatoid arthritis.